Interdisciplinary research
Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health.
Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.
Collaboration across the United States
The Nanovaccine Institute is a consortium of 82 researchers at 27 universities, research institutes, national laboratories, and companies, founded and coordinated by Iowa State University.
Revolutionizing how we prevent and treat disease
6 6
Focus Areas 82 82
Researchers 27 27
Institutions